Bettorf is one of several people to recently come forward with allegations that Takeda Pharmaceuticals Actos drug directly causes bladder cancer. He joins Nancy Rios, 54, of Reading, Pennsylvania, who says she now faces the possibility of losing her bladder. And Tommy Thompson, of New Orleans, Louisiana, who filed suit in federal court on September 9.
Like many around the country, Bettorf says his cancer was caused by long-term exposure to Actos. Recent FDA studies have indicated that those who take Actos for 12 months or longer are at a 40 percent higher risk for developing bladder cancer.
“An increased risk of bladder cancer was observed among patients with the longest exposure to Actos, as well as in those exposed to the highest cumulative does of Actos,” a Sept. 17 study said.
Despite early links to heart failure, Actos became the No. 1. diabetes drug in the United States, posting sales of $2.9 billion in 2006, and more than $4.3 billion in 2010. More than 2.3 million people were prescribed Actos, or similar drugs, in 2010.
As evidence mounts against Takeda, I wouldn’t be surprised if the pharmaceutical giant will face lawsuits numbering in the thousands.
If you or your loved is affected by adverse side effects of Actos, I would encourage you to seek legal action without delay. Rosenfeld Injury Lawyers remains committed to to helping you understand your legal rights, and to moving your case forward as quickly as possible.
What We Know and Don’t Know Huffington Post October 24, 2011
Lawsuit Accuses Diabetic Drug Manufacturer Takeda of Not Warning of Risks of Bladder Cancer The Louisiana Record September 16, 2011
Diabetes Drug Clouded in Lawsuits CBC – Canada August 5, 2011
FDA Safety Announcement Regarding Actos June 15, 2011